Rheonix Secures $6,000,000 New Funding Round

  • Feed Type
  • Date
    12/3/2013
  • Company Name
    Rheonix
  • Mailing Address
    22 Thornwood Drive Ithaca, NY 14850
  • Company Description
    Rheonix, Inc. is exploiting its novel, patented, polymer chip microfluidic technology to introduce products that address some of the hottest issues in global healthcare today: Avian Influenza, HPV, TB, Dengue Fever, AIDS, SARS, bioterrorism, affordable healthcare in developing nations, personalized medicine, and molecular diagnostics, to name a few.
  • Website
    http://www.rheonix.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $6,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
  • M&A Terms
  • Venture Investor
    Undisclosed